- About UsOur Story, Our Team & Support Information
- What We DoAdvocacy to Achieve the End of AIDS
- Accelerate Product Innovation & Availability
- Advance HIV/SRH Integration
- Advocate for Access to High-Impact Prevention
- Improve Research Conduct
- Promote Effective HIV Prevention Policy
- Strengthen Global Advocacy Networks
- Track and Translate the Field
- Our FocusInterventions to End the Epidemic
- ResourcesPublications, Infographics, Events & More
- MediaInformation & Resources for the Press
- Our BlogPrevention News & Perspective
Achieving
the
End of AIDS
Achieving
the
End of
AIDS
The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
- Deliver proven tools for immediate impacts.
- Demonstrate and roll out new HIV prevention tools.
- Develop long-term solutions to end the epidemic.
Spotlight
- January 14, 2022
On Wednesday, January 19, AVAC and partners shared critical insights and lessons from oral PrEP programs in Kenya, South Africa, and Zimbabwe. Learning from these efforts is essential to faster, smarter and more affordable rollout of future HIV prevention products.
- January 7, 2022
On Thursday, January 13, AVAC held Ups & Downs in the Field: Setting an Agenda Together for HIV Prevention in 2022, a webinar looking at the latest advances, disappointments and opportunities in HIV prevention.
- January 5, 2022
- December 22, 2021
We close the year with the exciting news that injectable cabotegravir has gained FDA approval as PrEP. It’s an important achievement, adding another much needed HIV prevention option to the mix.
What We Do
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
Px Methods
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.